Literature DB >> 19429752

Genotyping of Chlamydia trachomatis from the endocervical specimens of high-risk women in Hungary.

Fruzsina Petrovay1, Eszter Balla1, István Németh2, Éva Gönczöl3.   

Abstract

The distribution of different Chlamydia trachomatis serovars in Hungary has not been reported previously. The objective of this study was to determine the distribution and prevalence of C. trachomatis serovars in a high-risk population by genotyping. The endocervical specimens of 484 female sex workers (FSWs) were screened for C. trachomatis by plasmid PCR. Genotyping was performed in all C. trachomatis-positive samples by PCR-based RFLP analysis of the omp1 gene. A total of 32 specimens (6.6 %) were positive for C. trachomatis. Age was an important risk factor for C. trachomatis infection in FSWs. The highest prevalence was detected in women under the age of 20 (18.8 %). All positive specimens were successfully genotyped and seven serovars were identified. The most prevalent was serovar D (34.4 %), followed by E (21.9 %), F (18.8 %), G (9.4 %), J (9.4 %), H (3.1 %) and I (3.1 %). A heterogeneous distribution of C. trachomatis serovars was observed in the study group, where the most common serovars were D, E and F comprising 75 % of the positive samples. This PCR-based RFLP method could be used in epidemiological studies on the prevalence of C. trachomatis infection to provide more information and to compare the serovar distribution among different cohorts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429752     DOI: 10.1099/jmm.0.008607-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  10 in total

1.  Evaluation of a broadly protective Chlamydia-cholera combination vaccine candidate.

Authors:  F O Eko; D N Okenu; U P Singh; Q He; C Black; J U Igietseme
Journal:  Vaccine       Date:  2011-03-21       Impact factor: 3.641

2.  Evaluation of a high resolution genotyping method for Chlamydia trachomatis using routine clinical samples.

Authors:  Yibing Wang; Rachel J Skilton; Lesley T Cutcliffe; Emma Andrews; Ian N Clarke; Pete Marsh
Journal:  PLoS One       Date:  2011-02-11       Impact factor: 3.240

3.  Rectal administration of a chlamydial subunit vaccine protects against genital infection and upper reproductive tract pathology in mice.

Authors:  Roshan Pais; Yusuf Omosun; Qing He; Uriel Blas-Machado; Carolyn Black; Joseph U Igietseme; Kohtaro Fujihashi; Francis O Eko
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

4.  Emergence of the lymphogranuloma venereum L2c genovariant, Hungary, 2012 to 2016.

Authors:  Fruzsina Petrovay; Eszter Balla; Tímea Erdősi
Journal:  Euro Surveill       Date:  2017-02-02

5.  Prevalence of Chlamydia trachomatis Infection Diagnosed by Polymerase Chain Reaction in Female Sex Workers in a Northern Mexican City.

Authors:  Luis Francisco Sánchez-Anguiano; Nadia Velázquez-Hernández; Fernando Martín Guerra-Infante; Marisela Aguilar-Durán; Alma Rosa Pérez-Álamos; Sergio Estrada-Martínez; José Antonio Navarrete-Flores; Ada Agustina Sandoval-Carrillo; Elizabeth Irasema Antuna-Salcido; Jesús Hernández-Tinoco; Cosme Alvarado-Esquivel
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2019-02-02

6.  Prevalence of Chlamydia trachomatis in an asymptomatic female population attending cervical cytology services of three healthcare centers in Medellín, Colombia

Authors:  Nataly Orozco-Hoyos; Armando Baena; Carolina Montoya-Ruiz; Gloria I Sánchez; Eliana Restrepo
Journal:  Biomedica       Date:  2020-09-01       Impact factor: 0.935

7.  Chlamydia trachomatis genovar distribution in clinical urogenital specimens from Tunisian patients: high prevalence of C. trachomatis genovar E and mixed infections.

Authors:  Houda Gharsallah; Olfa Frikha-Gargouri; Hanen Sellami; Fatma Besbes; Abir Znazen; Adnene Hammami
Journal:  BMC Infect Dis       Date:  2012-11-30       Impact factor: 3.090

8.  A Multi-Component Prime-Boost Vaccination Regimen with a Consensus MOMP Antigen Enhances Chlamydia trachomatis Clearance.

Authors:  Alexander Badamchi-Zadeh; Paul F McKay; Bette T Korber; Guillermo Barinaga; Adam A Walters; Alexandra Nunes; João Paulo Gomes; Frank Follmann; John S Tregoning; Robin J Shattock
Journal:  Front Immunol       Date:  2016-04-28       Impact factor: 7.561

9.  Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.

Authors:  Pengfei Jiang; Wangqi Du; Yirong Xiong; Yan Lv; Juan Feng; Shanli Zhu; Xiangyang Xue; Shao Chen; Lifang Zhang
Journal:  Oncotarget       Date:  2015-12-22

Review 10.  Diagnosis of Chlamydia trachomatis genital infections in the era of genomic medicine.

Authors:  Seema Shetty; Christina Kouskouti; Uwe Schoen; Nikolaos Evangelatos; Shashidhar Vishwanath; Kapaettu Satyamoorthy; Franz Kainer; Angela Brand
Journal:  Braz J Microbiol       Date:  2021-06-23       Impact factor: 2.476

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.